#$%^&*AU2013100558A420130516.pdf#####it: 4l nse MovenWRPorbDCC\RXEu7100.40 2/ IJ/2 013 Abstract The present invention relates to stable compositions comprising a sphingosine 1 phosphate (S1P) receptor modulator, suitable for use as a dosage form. The S1 P receptor modulators are typically sphingosine analogues, such as 2-substituted 2-amino- propane1,3-diol or 2-amino-propanol derivatives, e. g. a compound comprising a group of formula.